Objective: To determine the incidence of and risk factors for unexplai
ned paroxysmal bradycardia in children treated with high-frequency osc
illatory ventilation (HFOV). Design: A nested case-control study. Sett
ing: A university-affiliated children's hospital. Subjects: All childr
en treated with HFOV for at least 3 days during a 2-year period and a
randomly chosen comparison group of 50 children treated with only conv
entional mechanical ventilation (CMV) for at least 3 days during the s
ame time period. Interventions: None. Measurements and results: Unexpl
ained paroxysmal sinus bradycardia occurred in six children (12%) rece
iving HFOV, and was significantly more common than in children treated
with CMV (0%). The bradycardic events occurred after the lung disease
started to improve, and the mean airway pressure (mPaw) at the time o
f the bradycardias was significantly decreased from the child's maxima
l mPaw. The bradycardic events were effectively treated acutely with m
anual ventilation or atropine sulfate, and resolved completely after t
he patient was changed to a regimen of CMV. Conclusion: Unexplained pa
roxysmal bradycardia associated with HFOV in children is not uncommon.
It completely resolves with conversion to CMV and may be related to o
verdistention of alveoli as compliance improves.